ArticleF1000Research2021

IMPORTANCE trial: a provisional study-design of a single-center, phase II, double-blinded, placebo-controlled, randomized, 4-week study to compare the efficacy and safety of intranasal esketamine in chronic opioid refractory pain.

Mauricio Fernandes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.